Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 133 results for "lacosamide"

BRIEF-UCB Phase 3 clinical study on VIMPAT meets primary effic...

Oct 28 (Reuters) - UCB SA : * Phase 3 clinical study evaluating VIMPAT (lacosamide) meets its primary efficacy endpoint * Study evaluated VIMPAT as adjunctive therapy in treatment of Japanese and Chinese adult patients with partial-onset ... Reuters UK, 2 days ago
PharmaAsia

9/15/14 - New indication for VIMPAT® lacosamide: UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset...

9/15/14 - New indication for VIMPAT lacosamide: UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset... New indication for VIMPAT lacosamide: UCB's anti-epileptic drug approved by FDA as ...
 Pharmacy Choice1 month ago FDA Okays Lacosamide Monotherapy in Partial-Onset Seizures  Diabetes Care1 month ago New Indication for Anti-Epileptic Drug Lacosamide (Vimpat)  Pharmscope1 month ago New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures  PR Newswire1 month ago
[x]  

Ranbaxy Laboratories : Patent Issued for Processes for Reducing Impurities in Lacosamide

By a News Reporter-Staff News Editor at Biotech Week -- Ranbaxy Laboratories Limited ( New Delhi , IN) has been issued patent number 8853453, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also ...
 4 Traders2 weeks ago

Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com

This report provides comprehensive information on the therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) ...
 Digital Journal1 week ago Global Sales of Epilepsy Drugs Market to Grow $5.35 billion by 2022 Says a New Report Available at MarketOptimizer.org  SearchBug1 month ago
[x]  
Digital Journal

FDA publishes list of drugs with new safety warnings

The latest FDA notification includes 32 products with safety labeling changes. This relates to boxed warnings, contradictions, precautions, and adverse reactions. Some of the more commonly used medications on the list include Nicorette. This product ...
 Digital Journal1 month ago

Patent Application Titled "A Pharmaceutical Composition Comprising the Phytocannabinoids Cannabidivarin (Cbdv) and Cannabidiol (Cbd)" Published Online

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Whalley, Benjamin (Reading, GB); Williams, Claire (Reading, GB); ...
 4 Traders1 month ago
Examiner.com

Fish oil reported to control epileptic seizures

Epileptic seizures affect approximately 3 million Americans; many of them have their seizures well controlled by medication; however, some continue to suffer from seizures despite treatment . This severely impacts their quality of life. Now, a new ...
 Examiner.com1 month ago Fish Oil May Ease Tough-To-Treat Epilepsy, University of California, Los Angeles (UCLA) Study  BioSpace1 month ago Low-doses of fish oil may reduce seizures in patients with drug-resistant epilepsy  Noodls1 month ago
MedPage Today

Morning Break: No Benefit from Double Mastectomy

Oncology/Hematology Published: Sep 3, 2014 ByMedPage Today Staff No survival benefit was seen with double mastectomy in breast cancer patients, compared with breast-conserving surgery and radiotherapy, a JAMA study found . Sanofi's ...
 MedPage Today1 month ago

Perampanel does not offer added benefit for patients with Epilepsy

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment according to the Act on the ...
 News-Medical.Net2 months ago Perampanel for epilepsy: Still no proof of added benefit  EurekAlert!2 months ago Still no proof of added benefit for perampanel in epilepsy  Medical News Today2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less